Ind-Swift Ltd

Ind-Swift Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ind-Swift Ltd

₹ 16.6 -1.25%
25 Jul - close price
indswiftltd.com BSE: 524652 NSE: INDSWFTLTD
About

Incorporated in 1986, Ind-Swift Ltd deals in manufacturing and exporting of pharmaceutical products

Key Points

Business Overview:[1]
Company has expertise in finished goods dosage, Active Pharmaceutical Ingredients (API’s) and herbal products. Company also diversified into multiple fields viz., Infrastructure, Printing, Packaging & Stationary, Education, and Media Publication with its every unit as an independent profit earning center

Website BSE NSE
  • Market Cap ₹ 90.1 Cr.
  • Current Price ₹ 16.6
  • High / Low ₹ 34.7 / 12.0
  • Stock P/E 11.5
  • Book Value ₹ -74.3
  • Dividend Yield 0.00 %
  • ROCE 11.9 %
  • ROE %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has delivered good profit growth of 18.2% CAGR over last 5 years

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 9.35% over past five years.
  • Contingent liabilities of Rs.72.4 Cr.
  • Earnings include an other income of Rs.328 Cr.
  • Working capital days have increased from -13.2 days to 64.5 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
106 95 104 107 106 149 116 103 135 114 136 120 145
96 90 93 89 98 130 105 98 121 111 122 112 148
Operating Profit 10 5 11 18 8 18 11 4 15 3 14 8 -3
OPM % 9% 5% 11% 17% 8% 12% 10% 4% 11% 3% 11% 7% -2%
7 2 1 3 67 6 3 3 46 40 5 2 281
Interest 14 15 15 15 14 15 18 15 14 10 10 10 10
Depreciation 8 7 7 7 7 7 7 7 7 5 5 6 7
Profit before tax -5 -15 -11 -1 53 2 -11 -15 40 28 4 -6 261
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 6% 0% 0% 0% 2%
-5 -15 -11 -1 53 2 -11 -15 38 28 4 -6 257
EPS in Rs -1.01 -2.85 -1.96 -0.19 9.80 0.44 -1.98 -2.76 6.93 5.21 0.76 -1.02 47.37
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
570 417 308 263 270 289 330 356 398 411 502 515
602 487 465 328 262 278 306 315 352 369 448 492
Operating Profit -32 -70 -157 -65 8 11 23 41 45 42 54 23
OPM % -6% -17% -51% -25% 3% 4% 7% 12% 11% 10% 11% 4%
11 2 13 -246 -20 34 22 14 24 72 53 328
Interest 77 40 19 16 7 3 29 52 57 60 63 39
Depreciation 26 39 36 36 35 34 34 33 32 29 27 24
Profit before tax -124 -147 -200 -363 -53 8 -17 -29 -20 26 16 288
Tax % -7% -2% 0% 0% 1% 0% 15% 1% 2% 0% 14% 2%
-116 -145 -200 -364 -54 8 -19 -30 -20 26 14 283
EPS in Rs -22.95 -28.83 -39.71 -67.25 -9.99 1.51 -3.53 -5.51 -3.70 4.81 2.63 52.33
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 2%
5 Years: 9%
3 Years: 9%
TTM: 3%
Compounded Profit Growth
10 Years: 7%
5 Years: 18%
3 Years: 33%
TTM: 132%
Stock Price CAGR
10 Years: 14%
5 Years: 46%
3 Years: 20%
1 Year: -23%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 10 10 10 11 11 11 11 11 11 11 11 11
Reserves 84 -64 -264 -636 -690 -688 -724 -706 -731 -716 -702 -413
1,024 1,054 1,061 1,062 1,055 1,010 1,017 1,023 1,036 993 1,014 874
272 228 254 232 237 265 298 344 316 361 331 257
Total Liabilities 1,390 1,228 1,061 669 613 598 602 672 632 649 654 728
440 404 374 342 311 291 270 244 236 216 184 243
CWIP 4 4 4 2 0 0 0 13 9 30 51 0
Investments 45 45 45 44 44 41 24 70 64 54 1 6
900 775 638 281 258 267 308 344 323 349 418 480
Total Assets 1,390 1,228 1,061 669 613 598 602 672 632 649 654 728

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
103 86 -106 7 1 43 35 83 50 73 15 16
-14 -6 -4 -4 -3 -14 -11 -17 -18 -29 77 3
-89 -81 110 -11 -4 -13 -26 -54 -45 -47 -42 -13
Net Cash Flow 0 -1 0 -8 -5 16 -3 12 -13 -3 50 6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 282 425 451 151 113 95 104 111 83 93 111 112
Inventory Days 202 117 151 86 108 112 102 123 120 150 83 150
Days Payable 152 155 290 356 426 454 440 454 353 393 262 143
Cash Conversion Cycle 331 387 311 -119 -206 -246 -234 -220 -149 -150 -68 120
Working Capital Days 317 325 409 -37 -57 -99 -79 -94 -69 -77 -27 64
ROCE % -4% -10% -20% -14% -4% -4% 2% 8% 11% 8% 13% 12%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58%
44.42% 44.40% 44.42% 44.42% 44.42% 44.42% 44.42% 44.42% 44.42% 44.43% 44.42% 44.42%
No. of Shareholders 14,42214,92714,78514,59013,74514,21916,43817,44018,02820,93621,36821,588

Documents

Announcements

Annual reports